SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BARONI, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.708
AS - Asia 3.157
EU - Europa 1.816
SA - Sud America 512
Continente sconosciuto - Info sul continente non disponibili 177
AF - Africa 64
OC - Oceania 16
Totale 11.450
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.527
SG - Singapore 1.188
CN - Cina 741
IT - Italia 517
VN - Vietnam 401
BR - Brasile 379
DE - Germania 309
HK - Hong Kong 234
GB - Regno Unito 196
UA - Ucraina 174
BD - Bangladesh 120
TR - Turchia 119
CA - Canada 100
PL - Polonia 97
FR - Francia 95
JP - Giappone 95
FI - Finlandia 89
RU - Federazione Russa 73
SE - Svezia 71
IN - India 58
MX - Messico 55
ID - Indonesia 52
AR - Argentina 46
NL - Olanda 39
ES - Italia 37
BE - Belgio 30
IQ - Iraq 29
EC - Ecuador 27
ZA - Sudafrica 27
PK - Pakistan 21
CZ - Repubblica Ceca 19
CO - Colombia 17
AT - Austria 15
AU - Australia 15
MA - Marocco 14
PE - Perù 13
LT - Lituania 12
MY - Malesia 12
UZ - Uzbekistan 11
VE - Venezuela 10
CL - Cile 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
AZ - Azerbaigian 7
KE - Kenya 7
PH - Filippine 7
IE - Irlanda 6
JM - Giamaica 6
RO - Romania 6
JO - Giordania 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
ET - Etiopia 4
GE - Georgia 4
GT - Guatemala 4
HN - Honduras 4
IL - Israele 4
PS - Palestinian Territory 4
PT - Portogallo 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
TN - Tunisia 4
IR - Iran 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
CH - Svizzera 2
DK - Danimarca 2
EU - Europa 2
HU - Ungheria 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
Totale 11.269
Salva come PNG Salva come JPEG
Città #
Singapore 755
Ashburn 644
San Jose 395
Fairfield 383
Woodbridge 361
Chandler 274
Beijing 258
Santa Clara 253
Hong Kong 227
Dallas 217
Houston 216
Ferrara 196
Ann Arbor 190
Seattle 169
Jacksonville 168
Wilmington 154
Ho Chi Minh City 132
Cambridge 123
New York 123
The Dalles 105
Los Angeles 100
Munich 93
Warsaw 91
Tokyo 89
Council Bluffs 85
Hanoi 84
Boardman 77
Izmir 66
Milan 63
Nanjing 59
Princeton 56
Lauterbourg 52
Orem 45
Jakarta 42
Shanghai 41
São Paulo 41
Dearborn 37
Mexico City 37
San Diego 33
Bremen 32
Helsinki 32
Montreal 28
Brooklyn 27
Toronto 27
Brussels 25
Chicago 23
Falls Church 23
Rome 23
Shenyang 23
Denver 22
Haiphong 22
London 22
Manchester 22
Nanchang 22
Turku 22
Da Nang 21
Hefei 21
Buffalo 19
Johannesburg 19
Moscow 19
Guangzhou 18
Poplar 18
Florence 17
Frankfurt am Main 17
Brno 16
Redwood City 16
Amsterdam 15
Phoenix 15
Verona 15
Hebei 14
Norwalk 14
Tianjin 14
Boston 13
Dong Ket 13
Atlanta 12
Biên Hòa 12
Bologna 12
Chennai 12
Jiaxing 12
Mcallen 11
Mumbai 11
Philadelphia 11
San Francisco 11
Baghdad 10
Columbus 10
Quito 10
Tashkent 10
Zhengzhou 10
Düsseldorf 9
North Bergen 9
Rio de Janeiro 9
San Mateo 9
Hải Dương 8
Montréal 8
Stockholm 8
Auburn Hills 7
Augusta 7
Baku 7
Belo Horizonte 7
Can Tho 7
Totale 7.492
Salva come PNG Salva come JPEG
Nome #
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 291
Hemostasis biomarkers in multiple sclerosis 259
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 252
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 248
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 244
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 244
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 241
Membrane binding and anticoagulant properties of protein S natural variants 240
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 240
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 237
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 222
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 218
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 216
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 213
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 211
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 211
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis 209
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 209
Plasma levels of soluble NCAM in multiple sclerosis 200
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 199
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 192
Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 191
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 190
Activated factor VII: antithrombin complex plasma concentration in subjects with or without angiographically demonstrated coronary artery disease and myocardial infarction 182
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 179
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 176
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 174
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 172
West Nile virus non-structural protein 1 promotes amyloid Beta deposition and neurodegeneration 172
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 167
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 166
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 165
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 164
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 161
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 159
Hemostasis gene expression of the internal jugular and saphenous veins 158
Release of Tissue Factor-bearing microparticles by human dendritic cells induced by stimulation of membrane P2X7 receptors 156
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 152
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury (P1.396) 150
Non-conventional therapeutic strategies for inherited disorders of hemostasis 149
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 148
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 147
Tratamiento y profilaxis de trastornos cardiovasculares con ácido erúcico 143
THE NATURAL ARG386CYS MUTATION IN THE COAGULATION FACTOR X, AS A TOOL TO INVESTIGATE DIFFERENT FX-REQUIREMENTS IN INITIATION AND PROPAGATION PHASES. 143
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 140
EFFECT OF SARS-CoV-2 ON THE COAGULATION CASCADE IN COVID-19 ASSOCIATED COAGULOPATHIES 137
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 130
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 128
Natural mutations in the EGF4 domain of protein S produce extended conformational changes and alter phospholipid and C4bBP interactions 125
The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones 123
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 121
NATURAL MUTATIONS IN THE EGF4 DOMAIN OF PROTEIN S PRODUCE EXTENDED CONFORMATIONAL CHANGES AND ALTER PHOSPHOLIPID AND C4BBP INTERACTIONS 117
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 117
The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII 117
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 113
Molecular characterization of factor X deficiency associated with borderline plasma factor X level 98
Mapping of inhibitory antibodies directed to the carboxy-terminus of FVIIa in severe FVII deficiency with elongated C-terminal variant (p.A354V-p.P464Hfs†) 97
null 94
null 93
Coagulation factor VII variants resistant to inhibitory antibodies. 93
Coagulation factor VII variants resistant to inhibitory antibodies 93
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 92
Immune response to treatment in a severe factor VII deficient patient: characterization of the inhibitory antibody and epitope-mapping 86
Plasma levels of hemostasis inhibitors and MRI outcomes in multiple sclerosis (P3.368) 86
null 84
Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis 83
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 73
null 73
Relationships among circulating levels of hemostasis inhibitors, chemokines, adhesion molecules, and mri characteristics in multiple sclerosis 66
Flavivirus Nonstructural Protein 1-Driven Coagulation via Tissue Factor-Bearing Microvesicles: A Pilot Study 64
null 56
null 45
SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic Profile 38
Roles of full-length and Δα1 HLA-G isoforms in NK-cell regulation and vascular SARS-CoV-2 infection 30
Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions. 26
SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic Profile 25
Genetic determinants of activated factor VII-antithrombin plasma levels and mortality in patients with coronary artery disease 21
Emerging viral infections: role of flavivirus NS1-mediated rewiring of PRR signaling 6
Totale 11.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022636 84 70 22 28 24 29 26 35 18 49 44 207
2022/2023634 60 64 23 87 92 88 46 50 67 8 37 12
2023/2024436 27 33 15 10 32 64 22 48 12 16 10 147
2024/20251.565 33 41 143 47 170 153 33 61 254 210 235 185
2025/20265.144 491 249 476 626 756 331 580 247 428 539 297 124
2026/2027137 137 0 0 0 0 0 0 0 0 0 0 0
Totale 11.450